Ginkgo Bioworks Holdings, Inc. (DNA)
NYSE: DNA · Real-Time Price · USD
8.12
-0.19 (-2.29%)
At close: May 13, 2025, 4:00 PM
8.11
-0.01 (-0.09%)
Pre-market: May 14, 2025, 8:36 AM EDT
Ginkgo Bioworks Holdings Employees
Ginkgo Bioworks Holdings had 834 employees as of December 31, 2024. The number of employees decreased by 384 or -31.53% compared to the previous year.
Employees
834
Change (1Y)
-384
Growth (1Y)
-31.53%
Revenue / Employee
$284,673
Profits / Employee
-$566,037
Market Cap
475.28M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 834 | -384 | -31.53% |
| Dec 31, 2023 | 1,218 | -74 | -5.73% |
| Dec 31, 2022 | 1,292 | 651 | 101.56% |
| Dec 31, 2021 | 641 | 146 | 29.49% |
| Dec 31, 2020 | 495 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
DNA News
- 6 days ago - Twist Bioscience and Ginkgo Bioworks Revise Collaboration - Business Wire
- 7 days ago - Ginkgo Bioworks Holdings, Inc. (DNA) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 7 days ago - Ginkgo Bioworks Reports First Quarter 2025 Financial Results - PRNewsWire
- 14 days ago - Phytolon and Ginkgo Bioworks Boost Natural Food Colors by Hitting Full-Project Milestone, Nearly Tripling the Manufacturing Efficiency of Phytolon's Innovative Colors - PRNewsWire
- 14 days ago - Ginkgo Bioworks Announces Date of First Quarter 2025 Results Presentation - PRNewsWire
- 22 days ago - Ginko Automation Partners with Aura Genetics to Accelerate Direct-to-Consumer Testing and Innovation - PRNewsWire
- 4 weeks ago - Ginkgo Bioworks Teams Up with Partners on ARPA-H Project to Stabilize Pharmaceutical Supply Chains - Using Amber Waves of Grain - PRNewsWire
- 5 weeks ago - Plex Research Partners With Ginkgo Bioworks on Artificial Intelligence (AI)-Powered Drug Discovery to Identify Novel Disease Mechanisms and Pathways - Business Wire